Tafnat (Tenofovir Alafenamide) Tablets is used for the treatment of patients with acute lymphoblastic leukemia (ALL)

Tafnat is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
Brand Name: Tafnat
Active Ingredients: Tenofovir Alafenamide
Manufactured By Natco Pharma
Strength: 25 mg
Dosage Form: Tablets
Retail Pack: 30 in a bottle

Tafnat (Tenofovir Alafenamide) Tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Tafnat (Tenofovir Alafenamide) Tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Tafnat (Tenofovir Alafenamide) Tablets medicine cost price in India.

The order for Tafnat (Tenofovir Alafenamide) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan for use in the treatment of HIV infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate (TAF). Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate (TDF), TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent.

Tafnat (Tenofovir Alafenamide) Tablets

Generic Name: Tenofovir Alafenamide

Tafnat (Tenofovir Alafenamide) Tablets

Tafnat (Tenofovir Alafenamide) Tablets is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support


Tafnat (Tenofovir Alafenamide) Tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Tafnat (Tenofovir Alafenamide) Tablets on prescription and Import License in Patient's Name only.

For overseas patients, Tafnat (Tenofovir Alafenamide) Tablets can be made available in Send your enquiry to find Tafnat (Tenofovir Alafenamide) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Tafnat (Tenofovir Alafenamide) Tablets.

For Tafnat (Tenofovir Alafenamide) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic For More Details

Emtricitabine and Tenofovir Alafenamide Combination for HIV-1 PrEP Gets FDA Approval For More Details